Psychiatrists have a long history of downplaying psychiatric drug risks and denying patients full informed consent. The APA says it “welcomes” antidepressant deprescribing, yet weakens…
New federal actions emphasize informed consent, holistic care, and protection for children and adults from psychiatric drug risks—but broader access to deprescribing support remains essential…
Fast-tracked psychedelics risk repeating psychiatric drug disasters as synthetic compounds are promoted as safe and natural, violating informed consent By CCHR InternationalThe Mental Health WatchdogMay…
Official psychiatric publication acknowledges diagnostic errors and prolonged antidepressant withdrawal—confirming concerns long raised by patients, researchers, and CCHR. By CCHR InternationalThe Mental Health Industry WatchdogFebruary…
Safety signals spanning decades have not removed many high-risk psychiatric drugs from the market, prompting renewed scrutiny of federal regulators, as long-reported harm intensifies concerns…